Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04972825 · ClinicalTrials.gov registry record · NA

AIR-B4: Mind the Gap

A NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders, sponsored by Health Resources and Services Administration (HRSA).

Active
Registry status
NA
Development phase
308
Enrollment target
4
Study locations

NCT04972825 is a NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders that is active but no longer recruiting, run by Health Resources and Services Administration (HRSA). The registered enrollment target is 308 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (130% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04972825, a NA study of Autism Spectrum Disorder and Neurodevelopmental Disorders, is active but no longer recruiting, sponsored by Health Resources and Services Administration (HRSA).

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
308 participants
Enrollment target
4
Study locations

Study Summary

The AIRB research team will compare the use and effectiveness of each intervention (Mind the Gap, Remaking Recess and Self Determination Learning Model of Instruction) with and without the addition of an implementation strategy, UNITED. In all groups, the research team will train community practitioners using remote delivery of professional development modules specific to the intervention, and active coaching for up to 12 sessions as dictated by the intervention procedures during a time span of 6 months. The research team will pair UNITED with three interventions that cover the ages of early childhood, childhood, and adolescence. These include Mind the Gap (MTG), a family navigation intervention for children newly diagnosed under age 8, Remaking Recess (RR), a school-based social/peer engagement intervention for children ages 5-12, and Self-Determination Learning Model of Instruction (SDMLI), a self-advocacy intervention for adolescents (13-22 years; 22 is the upper age limit of high school for individuals with disabilities). For MTG, peer navigators (staff working in an organization that already works with parents) and parents (with children with ASD) will meet via phone or video conference for up to 12 sessions within a 6 month span (an hour each time). They will go over sessions that were created by the research group that help parents understand the system of acquiring services. The total time commitment for peer navigators is about 18 hours and for parents with children with ASD is about 8.5 hours. Identified families connected to the community organization will be matched with one peer navigator who will then guide and support the caregiver through completion of the MTG modules with active coaching of the family. Family needs and preferences will guide topic selection. Active coaching will occur via zoom, or over the phone, based on family preference and some recorded sessions will be shared with the research group for analyses. Mind the Gap will be availab

Interventions

  • BEHAVIORAL Mind the Gap

Study Locations (4)

California

  • UC Davis MIND Institute - Davis

Kansas

  • University of Kansas - Lawrence

New York

  • University of Rochester - Rochester

Pennsylvania

  • UPENN - Philadelphia

Trial Details

FieldValue
Enrollment Target 308 participants
Start Date 2021-07-29
Est. Completion 2026-01-05
Phase NA

What the Registry Record Tells You About NCT04972825

The ClinicalTrials.gov registry entry for NCT04972825 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (130% higher). The listed sponsor is Health Resources and Services Administration (HRSA), which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mind the Gap is the first listed.

NCT04972825 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Kansas, New York.

Frequently Asked Questions

What is clinical trial NCT04972825 about?

NCT04972825 is a clinical study titled "AIR-B4: Mind the Gap". The AIRB research team will compare the use and effectiveness of each intervention (Mind the Gap, Remaking Recess and Self Determination Learning Model of Instruction) with and without the addition of an implementation strategy, UNITED. In all groups, the research team will train community practitio...

What is the current status of trial NCT04972825?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 308 participants. The study started on 2021-07-29. Estimated completion is 2026-01-05.

What conditions does trial NCT04972825 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Neurodevelopmental Disorders.

What interventions are being tested in trial NCT04972825?

The interventions under investigation include: Mind the Gap (BEHAVIORAL).

Who is sponsoring clinical trial NCT04972825?

This trial is sponsored by Health Resources and Services Administration (HRSA), which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04972825 being conducted?

This trial has 4 study locations across California, Kansas, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.